Mark Chin - 21 Apr 2022 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Reporting relationship: Former Director
Issuer ticker: PYXS
Reported as of: 21 Apr 2022
Net transaction value: -$5,324,571
SEC form: 4
Accepted by SEC: 25 Apr 2022, 12:12:03 UTC
Prior SEC filing: 04 Apr 2022
Next SEC filing: 03 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ Mark Chin

Key filing fact

Mark Chin filed Form 4 for Pyxis Oncology, Inc. (PYXS) on 25 Apr 2022.

Key facts

This page summarizes Mark Chin's Form 4 filing for Pyxis Oncology, Inc. (PYXS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 25 Apr 2022, 12:12.

Change

Previous filing in this sequence was filed on 04 Apr 2022.
Current net transaction value: -$5,324,571.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PYXS transaction

Common Stock

Sale

Transaction value: $5,324,571
Shares: -1,745,761
Change %: -100%
Price: $3.05
Shares after: 0
Date: 21 Apr 2022
Ownership: See footnote
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Mark Chin is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

The securities were held directly by Arix Bioscience Holdings Limited ("Arix"). The Reporting Person is one of for members of the Investment Committee of Arix and, in such capacity, may be deemed to share voting and dispositive power over the securities held by Arix. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his respective pecuniary interests therein.